Insulet Corp Reports Director Changes and Compensation Updates

Ticker: PODD · Form: 8-K · Filed: 2025-10-23T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, board-of-directors

Related Tickers: INS

TL;DR

INS board shakeup and exec pay changes filed. No major financial impact disclosed yet.

AI Summary

On October 21, 2025, Insulet Corporation (INS) filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the departure of a director, the election of a new director, and updates to compensatory arrangements for certain officers. Specific details regarding the financial impact of these changes were not provided in this excerpt.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance changes and executive compensation, which typically carry a low immediate risk.

Key Players & Entities

FAQ

What specific changes were made to Insulet Corporation's board of directors?

The filing indicates the departure of a director and the election of a new director, as reported on October 21, 2025.

Were there any changes to the compensation of Insulet Corporation's officers?

Yes, the filing mentions updates to the compensatory arrangements of certain officers.

What is the SEC file number for Insulet Corporation?

The SEC file number for Insulet Corporation is 001-33462.

In which state was Insulet Corporation incorporated?

Insulet Corporation was incorporated in Delaware.

What is the primary business address of Insulet Corporation?

The primary business address is 100 Nagog Park, Acton, Massachusetts 01720.

From the Filing

0001145197-25-000058.txt : 20251023 0001145197-25-000058.hdr.sgml : 20251023 20251023071845 ACCESSION NUMBER: 0001145197-25-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251021 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251023 DATE AS OF CHANGE: 20251023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 251411390 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20251021.htm 8-K podd-20251021 0001145197 FALSE 0001145197 2025-10-23 2025-10-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  October 21, 2025   INSULET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-33462 04-3523891 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. O n October 21, 2025, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Robbie Huffines as a Class II director, effective October 31, 2025. Mr. Huffines will stand for election by stockholders at the Company’s 2027 Annual Meeting of Stockholders. Mr. Huffines has been named to the Audit Committee of the Board, effective October 31, 2025. Mr. Huffines was a Global Chair of Investment Banking and a member of the Executive Committee at JP Morgan Chase & Co. from 2020 until he retired in 2024

View on Read The Filing